Interactions between N-methyl-D-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats

Pharmacology, Biochemistry, and Behavior
A BespalovR L Balster

Abstract

NMDA receptor antagonists have previously been reported to alter some pharmacological and behavioral effects of acute and chronic opioid administration. The present study assessed the interactions of NMDA antagonists with the discriminative stimulus properties of morphine. Adult male Long Evans rats were trained to discriminate 3.2 mg/kg of s.c. morphine from water under a two-lever fixed-ratio 10 schedule of food reinforcement. During test sessions. I.p. injections of the noncompetitive NMDA receptor antagonist dizocilpine (0.03-0.2 mg/kg), the competitive antagonists NPC 17742 (1-16 mg/kg), and SDZ 220-581 (0.1-3 mg/kg), the polyamine site antagonist eliprodil (3-17.3 mg/kg), the glycine-site partial agonist (+)-HA-966 (3-56 mg/kg), and the nonselective glutamate antagonist kynurenic acid (30-150 mg/kg) were coadministered with s.c. morphine (1-3.2 mg/kg; interaction tests) or water (generalization tests). In generalization tests, none of the compounds completely substituted for morphine. Concurrent administration of morphine and NMDA antagonists did not greatly alter the discriminative stimulus properties of morphine. Various doses of NPC 17742, SDZ 220-581, or (+)-HA-966 somewhat increased levels of morphine-appropriate lev...Continue Reading

References

Nov 10, 1976·Psychopharmacology·H E Shannon, S G Holtzman
Mar 1, 1991·Pharmacology, Biochemistry, and Behavior·K A Trujillo, H Akil
Aug 1, 1991·Pharmacology, Biochemistry, and Behavior·R S Mansbach, R L Balster
Sep 4, 1991·European Journal of Pharmacology·R S Mansbach
Jan 28, 1991·Neuroscience Letters·S TanganelliL Beani
Jan 1, 1987·Psychopharmacology·M W Emmett-Oglesby, A Herz
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·E H WongL L Iversen
Jul 1, 1986·Pharmacology, Biochemistry, and Behavior·D M ThompsonJ M Moerschbaecher
Feb 1, 1973·European Journal of Pharmacology·J A RosecransI D Hirschhorn
Aug 1, 1981·Journal of Clinical Pharmacology·R G Browne, A Weissman
Nov 3, 1994·European Journal of Pharmacology·A BespalovE Zvartau
Jun 30, 1994·Behavioural Brain Research·H Dai, R J Carey
Aug 30, 1994·Proceedings of the National Academy of Sciences of the United States of America·J LiuF R Sharp
Apr 1, 1993·Neuropharmacology·D M GrechR L Balster
Oct 29, 1993·Brain Research·H B Gutstein, K A Trujillo
Dec 1, 1995·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·B H HermanP Bridge
Aug 1, 1995·Behavioural Pharmacology·W. DanyszC.G. Parsons
Aug 1, 1995·Behavioural Pharmacology·R.L. BalsterE. Weber

❮ Previous
Next ❯

Citations

Mar 29, 2001·Pharmacology, Biochemistry, and Behavior·I A Sukhotina
Oct 9, 1999·Pharmacology, Biochemistry, and Behavior·W Koek
Nov 17, 2001·Behavioural Pharmacology·M GaiardiM Bartoletti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.